Ironwood Pharmaceuticals (IRWD)
(Delayed Data from NSDQ)
$8.51 USD
-0.51 (-5.65%)
Updated Mar 18, 2024 04:00 PM ET
After-Market: $8.51 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth D Momentum C VGM
Price, Consensus and EPS Surprise
IRWD 8.51 -0.51(-5.65%)
Will IRWD be a Portfolio Killer in March?
Zacks Investment Research is releasing its prediction for IRWD based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for IRWD
Ironwood (IRWD) Q4 Earnings Miss, Revenues Beat Marginally
Ironwood Pharmaceuticals (IRWD) Reports Break-Even Earnings for Q4
IRWD: What are Zacks experts saying now?
Zacks Private Portfolio Services
Ironwood (IRWD) is on the Move, Here's Why the Trend Could be Sustainable
Wall Street Analysts Think Ironwood (IRWD) Could Surge 37.6%: Read This Before Placing a Bet
Ironwood's (IRWD) Q3 Earnings Miss Mark, Linzess Volume Rises
Other News for IRWD
Ironwood Pharmaceuticals (NASDAQ:IRWD): Analysts Stay Bullish Despite Recent Stock Plunge
Top 3 Health Care Stocks That Could Lead To Your Biggest Gains In March
Ironwood Pharmaceuticals Inc (IRWD) CFO Sravan Emany Acquires 10,684 Shares
It’s Time! 3 Failing Biotech Stocks to Sell Right Now
Ironwood put volume heavy and directionally bearish